Chancellor Reeves Plans Specific Measures on Household Expenses in Forthcoming Budget
Treasury head Reeves has revealed she is planning "targeted steps to address cost of living issues" in next month's Budget.
Speaking to the BBC, she noted that curbing inflation is a collective task of both the administration and the central bank.
The United Kingdom's inflation rate is forecast to be the highest among the G7 industrialized countries this calendar year and next.
Possible Utility Bill Interventions
Reports indicate the administration could take action to bring down energy bills, for instance by cutting the current 5% rate of value-added tax applied on energy.
A further approach is to lower some of the policy costs presently added to household expenses.
Budgetary Constraints and Expert Expectations
The government will receive the latest assessment from the independent fiscal watchdog, the OBR, on the start of the week, which will show how much scope there is for these actions.
The consensus from the majority of economists is that the Chancellor will have to announce higher taxes or spending cuts in order to meet her declared debt limits.
Earlier on the same day, analysis indicated there was a twenty-two billion pound deficit for the chancellor to fill, which is at the more modest range of projections.
"It is a collective responsibility between the central bank and the administration to further reduce some of the causes of inflation," Reeves informed the BBC in the US capital, at the conferences of the International Monetary Fund and World Bank.
Revenue Pledges and Global Issues
While a great deal of the attention has been on probable tax increases, the Treasury chief said the latest figures from the OBR had not changed her pledge to campaign commitments not to raise rates on income tax, VAT or social security contributions.
She attributed an "unpredictable global environment" with growing international and trade concerns for the fiscal tax moves, likely to be focused on those "with the broadest shoulders."
International Trade Disputes
Commenting on concerns about the United Kingdom's trade ties with the Asian nation she said: "Our security interests always come first."
Last week's declaration by Chinese authorities to increase trade restrictions on critical minerals and other resources that are crucial for advanced tech manufacturing led American leader Donald Trump to threaten an extra 100% tariff on goods from the Asian country, increasing the risk of an full-scale trade war between the two economic giants.
The US Treasury Secretary called China's decision "commercial pressure" and "a global supply chain power grab."
Asked about accepting the US offer to participate in its dispute with China, Reeves said she was "deeply worried" by Chinese actions and urged the Chinese government "not to put up barriers and restrict access."
She said the action was "harmful for the world economy and creates additional obstacles."
"In my view there are areas where we need to confront Chinese policies, but there are also significant prospects to sell into China's economy, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."
The chancellor also affirmed she was cooperating with international partners "regarding our own essential resources plan, so that we are reduced dependence."
Health Service Drug Pricing and Funding
Reeves also admitted that the cost the National Health Service spends on drugs could rise as a consequence of current talks with the Trump administration and its pharmaceutical firms, in return for lower tariffs and capital.
A number of the biggest global pharmaceutical manufacturers have said recently that they are either halting or scrapping operations in the UK, with several blaming the low prices they are receiving.
Recently, the government science advisor said the cost the NHS spends on drugs would have to rise to prevent businesses and drug research funding departing from the United Kingdom.
Reeves told media: "We have seen because of the payment system, that medical research, recent pharmaceuticals have not been provided in the United Kingdom in the manner that they are in other EU nations."
"We want to ensure that people getting care from the National Health Service are can obtain the top essential treatments in the world. And so we are reviewing these issues, and... looking to secure additional investment into the UK."